• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低至极低风险前列腺癌患者前列腺活检与前列腺癌根治术标本的病理数据比较。

Comparison of pathological data between prostate biopsy and radical prostatectomy specimen in patients with low to very low risk prostate cancer.

作者信息

Lendínez-Cano G, Alonso-Flores J, Beltrán-Aguilar V, Cayuela A, Salazar-Otero S, Bachiller-Burgos J

机构信息

Servicio de Urología, Consorcio Sanitario Público Aljarafe, Hospital San Juan de Dios del Aljarafe, Bormujos, Sevilla, España.

Servicio de Urología, Consorcio Sanitario Público Aljarafe, Hospital San Juan de Dios del Aljarafe, Bormujos, Sevilla, España.

出版信息

Actas Urol Esp. 2015 Oct;39(8):482-7. doi: 10.1016/j.acuro.2015.02.005. Epub 2015 Apr 18.

DOI:10.1016/j.acuro.2015.02.005
PMID:25895440
Abstract

OBJECTIVE

To analyze the correlation between pathological data found in radical prostatectomy and previously performed biopsy in patients at low risk prostate cancer.

MATERIAL AND METHODS

A descriptive, cross-sectional study was conducted to assess the characteristics of radical prostatectomies performed in our center from January 2012 to November 2014. The inclusion criteria were patients with low-risk disease (cT1c-T2a, PSA≤10ng/mL and Gleason score≤6). We excluded patients who had fewer than 8 cores in the biopsy, an unspecified number of affected cores, rectal examinations not reported in the medical history or biopsies performed in another center.

RESULTS

Of the 184 patients who underwent prostatectomy during this period, 87 met the inclusion criteria, and 26 of these had<3 affected cores and PSA density≤.15 (very low risk). In the entire sample, the percentage of undergrading (Gleason score≥7) and extracapsular invasion (pT3) was 18.4% (95% CI 10.3-27.6) and 10.35% (95% CI 4.6-17.2), respectively. The percentage of positive margins was 21.8% (95% CI 12.6-29.9). In the very low-risk group, we found no cases of extracapsular invasion and only 1 case of undergrading (Gleason 7 [3+4]), representing 3.8% of the total (95% CI 0-12.5). Predictors of no correlation (stage≥pT3a or undergrading) were the initial risk group, volume, PSA density and affected cores.

CONCLUSIONS

Prostate volume, PSA density, the number of affected cores and the patient's initial risk group influence the poor pathological prognosis in the radical prostatectomy specimen (extracapsular invasion and Gleason score≥7).

摘要

目的

分析低危前列腺癌患者根治性前列腺切除术中发现的病理数据与之前进行的活检之间的相关性。

材料与方法

进行了一项描述性横断面研究,以评估2012年1月至2014年11月在本中心进行的根治性前列腺切除术的特征。纳入标准为低危疾病患者(cT1c - T2a,PSA≤10ng/mL且Gleason评分≤6)。我们排除了活检组织芯少于8个、受累组织芯数量未明确、病史中未报告直肠检查或在其他中心进行活检的患者。

结果

在此期间接受前列腺切除术的184例患者中,87例符合纳入标准,其中26例受累组织芯<3个且PSA密度≤0.15(极低危)。在整个样本中,分级过低(Gleason评分≥7)和包膜外侵犯(pT3)的百分比分别为18.4%(95%可信区间10.3 - 27.6)和10.35%(95%可信区间4.6 - 17.2)。切缘阳性的百分比为21.8%(95%可信区间12.6 - 29.9)。在极低危组中,未发现包膜外侵犯病例,仅1例分级过低(Gleason 7 [3 + 4]),占总数的3.8%(95%可信区间0 - 12.5)。无相关性(分期≥pT3a或分级过低)的预测因素为初始风险组、体积、PSA密度和受累组织芯。

结论

前列腺体积、PSA密度、受累组织芯数量和患者的初始风险组会影响根治性前列腺切除标本的不良病理预后(包膜外侵犯和Gleason评分≥7)。

相似文献

1
Comparison of pathological data between prostate biopsy and radical prostatectomy specimen in patients with low to very low risk prostate cancer.低至极低风险前列腺癌患者前列腺活检与前列腺癌根治术标本的病理数据比较。
Actas Urol Esp. 2015 Oct;39(8):482-7. doi: 10.1016/j.acuro.2015.02.005. Epub 2015 Apr 18.
2
The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.前列腺特异性抗原(PSA)密度预测初始前列腺活检和前列腺切除术中 Gleason 评分升级的能力随着肿瘤分级的增加而降低,这是由于单位肿瘤体积的 PSA 分泌减少所致。
BJU Int. 2012 Jul;110(1):36-42. doi: 10.1111/j.1464-410X.2011.10681.x. Epub 2011 Nov 15.
3
Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.对于接受广泛经直肠超声引导活检方案诊断的低危前列腺癌患者,单侧阳性活检并不能预测根治性前列腺切除术后的单侧前列腺癌。
BJU Int. 2012 Jul;110(2 Pt 2):E64-8. doi: 10.1111/j.1464-410X.2011.10762.x. Epub 2011 Nov 17.
4
The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.前列腺穿刺活检标本中癌阳性核心的百分比强烈预测根治性前列腺切除术中的肿瘤分期和体积。
J Urol. 2000 Jan;163(1):174-8.
5
The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.前列腺穿刺活检癌灶在穿刺活检受累更严重一侧的百分比作为根治性前列腺切除术后前列腺特异性抗原复发的预测指标:来自共享平等准入区域癌症医院(SEARCH)数据库的结果
Cancer. 2003 Dec 1;98(11):2344-50. doi: 10.1002/cncr.11809.
6
Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.使用基于前列腺特异性抗原密度和活检Gleason评分的新型风险分组系统改善根治性前列腺切除术后生化复发的风险分层。
J Urol. 2002 Jul;168(1):110-5.
7
Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.前列腺穿刺活检组织中癌灶所占百分比是前列腺癌根治术后前列腺特异性抗原复发的重要独立预测因素:来自SEARCH数据库的结果
J Urol. 2003 Jun;169(6):2136-41. doi: 10.1097/01.ju.0000065588.82511.06.
8
Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.前列腺腺癌,核心穿刺活检 Gleason 评分 9-10:与根治性前列腺切除术的相关性及预后。
J Urol. 2013 Dec;190(6):2068-73. doi: 10.1016/j.juro.2013.05.056. Epub 2013 May 30.
9
Predictors for clinically relevant Gleason score upgrade in patients undergoing radical prostatectomy.接受根治性前列腺切除术患者中临床相关 Gleason 评分升级的预测因素。
BJU Int. 2012 Jan;109(2):214-9. doi: 10.1111/j.1464-410X.2011.10187.x. Epub 2011 May 18.
10
Evaluation of concordance of Gleason score between prostate biopsy and radical prostatectomy.前列腺活检与根治性前列腺切除术中 Gleason 评分一致性的评估。
Tunis Med. 2018 Jul;96(7):430-436.

引用本文的文献

1
Deep learning based on 68Ga-PSMA-11 PET/CT for predicting pathological upgrading in patients with prostate cancer.基于68Ga-PSMA-11 PET/CT的深度学习用于预测前列腺癌患者的病理升级
Front Oncol. 2024 Jan 8;13:1273414. doi: 10.3389/fonc.2023.1273414. eCollection 2023.
2
Is possible to rule out clinically significant prostate cancer using PI-RADS v2 for the assessment of prostate MRI?使用 PI-RADS v2 评估前列腺 MRI 能否排除临床上有意义的前列腺癌?
Int Braz J Urol. 2019 Jul-Aug;45(4):724-731. doi: 10.1590/S1677-5538.IBJU.2018.0382.